. Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron - IOPAC Press "Enter" to skip to content

Governments near agreement on package of amendments to the International Health Regulations (2005)
- All WHO news
In the eighth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR), which was suspended yesterday...
WHO and France convene high-level meeting to defeat meningitis
- All WHO news
<p>Global<strong> </strong>leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted...
WHO reports widespread overuse of antibiotics in patients hospitalized with COVID-19
- All WHO news
<p>New evidence from the World Health Organization (WHO) shows the extensive overuse of antibiotics during COVID-19 pandemic worldwide, which may...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron

By iopac on June 15, 2023

The relative risk reduction for participants who received adintrevimab as post-exposure prophylaxis was 75%.

Published in COVID-19

iopac